400
Participants
Start Date
July 22, 2016
Primary Completion Date
December 27, 2018
Study Completion Date
April 30, 2019
Udenafil
Active drug
Placebo
Matching Placebo
Children's Hospital of New York, New York
Sejong General Hospital, Bucheon-si
Children's Hospital of Philadelphia, Philadelphia
Nemours Cardiac Center/Alfred I. duPont Hospital for Children, Wilmington
Children's National Medical Center, Washington D.C.
Duke University Medical Center, Durham
Medical University of South Carolina, Charleston
Children's Healthcare of Atlanta, Atlanta
Johns Hopkins All Children's Heart Institute, St. Petersburg
Vanderbilt University Medical Center, Nashville
Nationwide Children's Hosptial, Columbus
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children/Herman B. Wells Center for Pediatric Research, Indianapolis
Children's Hospital of Wisconsin, Milwaukee
Washington University St. Louis/St.Louis Children's Hospital, St Louis
Children's Mercy Hospital Kansas City, Kansas City
University of Nebraska Children's Hospital and Medical Center, Omaha
Texas Children's Hospital, Houston
Children's Hospital Colorado, Aurora
Primary Children's Medical Hospital/Dept. of Pediatric Cardiology, Salt Lake City
Phoenix Children's Hospital/Children's Heart Center at Phoenix Children's Hospital, Phoenix
Children's Hospital Los Angeles, Los Angeles
Cedars/Sinai Heart Institute, Los Angeles
Rady Children's Hospital, San Diego
Seattle Children's Hosptial, Seattle
Boston Children's Hospital, Boston
University of Michigan Congenital Heart Center/C.S. Mott Children's Hospital, Ann Arbor
Stollery Children's Hospital - University of Alberta, Edmonton
The Hospital for Sick Children, Toronto
Seoul National University Children's Hospital, Seoul
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Mezzion Pharma Co. Ltd
INDUSTRY